ClearBridge Investments’s Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A BSX.PRA Stock Holding History
Bought
Maintained
Sold
Other funds holding BSX.PRA
ClearBridge Investments's BSX.PRA Position: Q2 2023 in Review
ClearBridge Investments sold out of Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A (BSX.PRA) in Q2 2023, closing a stake of 32,118 shares — an estimated $3.89M sold.
ClearBridge Investments first reported a position in BSX.PRA in Q2 2020 and held it in 8 quarters. The position peaked at $9.62M in Q3 2020. 1 fund tracked by Wall St. Rank holds BSX.PRA as of Q2 2023.
- ClearBridge Investments reported no remaining Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A position as of Q2 2023 after selling out during the quarter.
- ClearBridge Investments sold 32,118 Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A shares in Q2 2023, an estimated $3.89M.
- ClearBridge Investments first reported a position in Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A in Q2 2020 and held it in 8 quarters.
- ClearBridge Investments's Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A position peaked at $9.62M in Q3 2020.
- 1 fund tracked by Wall St. Rank held Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A as of Q2 2023.
Based on ClearBridge Investments's 13F filing for Q2 2023, filed 11 Aug 2023.